This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca (AZN.L) – Pfizer is putting together a sweetened offer before it considers whether to make a hostile takeover attempt by bringing its proposal directly to AstraZeneca’s shareholders. Closing Price 4610.00p (Bloomberg).
easyJet (EZJ.L) – Reported a forecast-beating narrower seasonal first-half loss as it held down costs and said it was on track to continue to deliver sustainable growth and returns for shareholders. Revenue £1.7bn (£1.68bn expected). Closing Price 1730.00p (Reuters)
Taylor Wimpey (TW.L) – UK housing market continues to perform strongly with sales rates and pricing at upper end of expectations. Closing Price 106.30p (Reuters)
TUI Travel (TT.L) – Posted an operating loss of £298m vs. £289m it lost in the same period last year. H1 loss compares to forecasts of a loss of £305m from Morgan Stanley analysts and a loss of £315m from Deutsche Bank analysts. Closing Price 441.60p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Centrica | CAN.L | -0.16% | 0.28% | -0.75% |
| Lonmin | LMI.L | -4.07% | 2.58% | -4.10% |
| Premier Oil | PMO.L | 0.75% | 1.01% | -0.49% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research